ATE469902T1 - Amorphe substanz eines tricyclischen triazolobenzazepinderivats - Google Patents

Amorphe substanz eines tricyclischen triazolobenzazepinderivats

Info

Publication number
ATE469902T1
ATE469902T1 AT02790871T AT02790871T ATE469902T1 AT E469902 T1 ATE469902 T1 AT E469902T1 AT 02790871 T AT02790871 T AT 02790871T AT 02790871 T AT02790871 T AT 02790871T AT E469902 T1 ATE469902 T1 AT E469902T1
Authority
AT
Austria
Prior art keywords
amorphous substance
derivative
tricyclic triazolobenzazepine
tricyclic
triazolobenzazepine derivative
Prior art date
Application number
AT02790871T
Other languages
English (en)
Inventor
Toyoaki Ishikura
Takayuki Ishizawa
Kenji Suemune
Mayumi Ishiwata
Chikako Udagawa
Original Assignee
Meiji Seika Kaisha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Seika Kaisha filed Critical Meiji Seika Kaisha
Application granted granted Critical
Publication of ATE469902T1 publication Critical patent/ATE469902T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT02790871T 2001-12-26 2002-12-25 Amorphe substanz eines tricyclischen triazolobenzazepinderivats ATE469902T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2001393016 2001-12-26
PCT/JP2002/013558 WO2003055886A1 (en) 2001-12-26 2002-12-25 Amorphous substance of tricyclic triazolobenzazepine derivative

Publications (1)

Publication Number Publication Date
ATE469902T1 true ATE469902T1 (de) 2010-06-15

Family

ID=19188739

Family Applications (2)

Application Number Title Priority Date Filing Date
AT02790871T ATE469902T1 (de) 2001-12-26 2002-12-25 Amorphe substanz eines tricyclischen triazolobenzazepinderivats
AT02790870T ATE410427T1 (de) 2001-12-26 2002-12-25 Neues kristallines tricyclisches triazolobenzazepinderivat

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT02790870T ATE410427T1 (de) 2001-12-26 2002-12-25 Neues kristallines tricyclisches triazolobenzazepinderivat

Country Status (11)

Country Link
US (2) US7229985B2 (de)
EP (2) EP1469000B1 (de)
JP (2) JP4376628B2 (de)
KR (1) KR100848724B1 (de)
CN (1) CN1275968C (de)
AT (2) ATE469902T1 (de)
AU (2) AU2002367110A1 (de)
CA (1) CA2471651C (de)
DE (2) DE60229298D1 (de)
ES (2) ES2346858T3 (de)
WO (2) WO2003055886A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070167432A1 (en) * 2003-06-19 2007-07-19 Meiji Seila Kaisha, Ltd Tricyclic triazolobenzapine derivative produced as novel crystalline substance
JPWO2004113451A1 (ja) * 2003-06-20 2006-08-17 明治製菓株式会社 難溶性物質と水溶性高分子との共沈物およびその製造方法
EP1994931A4 (de) * 2006-03-02 2010-12-01 Meiji Seika Kaisha Prophylaktisches oder therapeutisches mittel gegen allergische augenerkrankungen oder allergische nasenerkrankungen mit einem tricyclischen triazolobenzoazepin-derivat
TW200843903A (en) * 2007-05-03 2008-11-16 Univ Nat Central Abrasives with function of sliding grinding and its manufacturing method
KR101216756B1 (ko) * 2007-12-18 2012-12-28 메이지 세이카 파루마 가부시키가이샤 염증성 장질환의 예방 또는 치료제
JP5381978B2 (ja) * 2008-04-02 2014-01-08 アステラス製薬株式会社 アミド誘導体含有医薬組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0888350A1 (de) 1996-03-08 1999-01-07 Zeneca Limited Azolobenzazepinderivate als neurologisch aktive mittel
US6574603B1 (en) * 1997-09-26 2003-06-03 Gilbarco Inc. In-vehicle ordering
DK1026167T3 (da) * 1997-09-29 2003-05-26 Meiji Seika Kaisha Tricykliske triazolobenzazepinderivater, fremgangsmåde til fremstilling af disse samt antiallergiske midler

Also Published As

Publication number Publication date
US20050130955A1 (en) 2005-06-16
DE60236623D1 (de) 2010-07-15
DE60229298D1 (de) 2008-11-20
AU2002367110A1 (en) 2003-07-15
CN1617872A (zh) 2005-05-18
JP4376628B2 (ja) 2009-12-02
AU2002367109A1 (en) 2003-07-15
US20050020579A1 (en) 2005-01-27
EP1466914B1 (de) 2010-06-02
EP1469000A1 (de) 2004-10-20
US7002009B2 (en) 2006-02-21
ES2312650T3 (es) 2009-03-01
ATE410427T1 (de) 2008-10-15
EP1466914A4 (de) 2005-12-07
WO2003055885A1 (en) 2003-07-10
CA2471651A1 (en) 2003-07-10
WO2003055886A1 (en) 2003-07-10
EP1469000B1 (de) 2008-10-08
EP1469000A4 (de) 2005-12-07
ES2346858T3 (es) 2010-10-21
KR20040072682A (ko) 2004-08-18
CN1275968C (zh) 2006-09-20
KR100848724B1 (ko) 2008-07-25
US7229985B2 (en) 2007-06-12
JPWO2003055885A1 (ja) 2005-05-12
CA2471651C (en) 2010-01-26
EP1466914A1 (de) 2004-10-13
JPWO2003055886A1 (ja) 2005-09-02

Similar Documents

Publication Publication Date Title
EE200100594A (et) Uudsed ravimikompositsioonid, mis põhinevad antikolinergiliselt toimivatel ühenditel ja ß-mimeetikumidel
ATE431733T1 (de) Pharmazeutische zusammensetzung enthaltend epothilone
SE9900100D0 (sv) New compounds
ES2172864T3 (es) 2-metoxibenzofenonas fungicidas.
DE60032780D1 (de) Tetrahydroquinolin-derivate
PT1191025E (pt) Cristais de lansoprazol
DK1216225T3 (da) Nye aminodicarboxylsyrederivater med farmaceutiske egenskaber
DE60019577D1 (de) 4, 5, 6, 7-tetrahydroindazolderivate als antitumormittel
DK1589017T3 (da) 12,13-modificerede epothilon-derivater
DK1157023T3 (da) C-21-modificerede epothiloner
ATE302782T1 (de) Substituierte 1-oxa-2,8-diaza-spiro(4,5)dec-2-en- derivate als arzneimittel gegen schmerz
ATE465733T1 (de) Substituierte indeno-ä1,2-cü-isochinolin-derivate und verwendungszwecke dafür
MA27349A1 (fr) Composition cristalline renfermant de l'escitalopram.
AU2002349777A1 (en) Novel benzophenone derivatives or salts thereof
FI920023A0 (fi) Heteroarylpiperazinfoereningar som antipsykotiska aemnen.
ES2166046T3 (es) Derivados de arilacrilamida como agonistas o antagonistas de 5ht1.
DE50107988D1 (de) Substituierte 1,2,3,4-tetrahydrochinolin-2-carbonsäurederivate
ECSP045162A (es) "composiciones farmaceuticas a base de derivados de azetidina"
ID28601A (id) Proses penyiapan senyawa-senyawa 1,4-dihidropiridin
AR028607A1 (es) Derivados de 1,4-diazepan-2,5-diona
DE60236623D1 (de) Amorphe substanz eines tricyclischen triazolobenzazepinderivats
BR9713176A (pt) Benzotiofenos amorfos,métodos de preparação e métodos de uso
NO20013878D0 (no) (1-fenacy-3-fenyl-3-piperidylety1)piperidin-derivater, fremgangsmate for fremstilling derav og farmasoytiske preparaterinneholdende de samme
IS6159A (is) Fjölgervingar af kristölluðu asabísýkló (2,2,2) oktan-3-amín sítrati og lyfjasamsetningar
EE200400016A (et) Protsess 1,5-diarüül-3-trifluorometüül-delta²-pürasoliinide ratseemiliste ja enantiomeerselt puhaste derivaatide valmistamiseks

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties